Learn how US health care regulation and policy may change in the wake of the US Supreme Court's 2024 decision overturning the Chevron doctrine, as well as takeaways for your organization.
This article discusses the US Department of Health and Human Services (HHS) final rule amending Health Insurance Portability and Accountability Act (HIPAA) privacy regulations to provide significant additional protections for protected health information relating to reproductive health care.
On April 23, 2024, the U.S. Federal Trade Commission finalized a rule, by a vote of 3-2, abolishing the vast majority of employee covenants not to compete across the United States.
While certain health care providers will be exempted from the rule, many will not. As such, and if the rule survives legal challenge, health care industry participants should carefully consider how the rule will impact their recruitment and retention strategies going forward.
This resource covers how to create and enforce effective document retention policies, especially for organizations in the health-care industry.
In February 2024, the U.S. Department of Health and Human Services (HHS) issued the much anticipated final rule to update the Confidentiality of Substance Abuse Disorder Patient Records regulations at 42 CFR Part 2 (Part 2).
This article discusses the amendments to Part 2 and its most impactful revisions, including the amendments to loosen patient consent requirements, regulate SUD counseling notes, and create new patient rights and breach notification requirements.
The multi-jurisdictional guide explores pricing and reimbursement laws and regulations impacting healthcare and pharmaceutical sectors.
The U.S. Supreme Court’s decision overturning Chevron deference. This articles discusses the ruling, which calls for courts to reassume their role as interpreters of the law.
This article provides an overview of the False Claims Act (FCA).
In this article you will learn about, the types of FCA cases in health care, damages and penalties under the FCA, and cooperation considerations for companies and individuals under government scrutiny.
US Attorney General Pam Bondi has renewed the prior Trump administration’s prohibition on the use of sub-regulatory guidance, potentially altering the landscape for False Claims Act cases pursued during the second Trump administration.
This is sample tool helping organizations assess whether a security incident involving personal information would require notification under the HIPAA breach notification rule (under the US Health Insurance Portability and Accountability Act).